Bruce C. Conway
Director/Board Member bij Trigemina, Inc.
Profiel
Bruce C.
Conway is on the board of Trigemina, Inc.
Actieve functies van Bruce C. Conway
Bedrijven | Functie | Begin |
---|---|---|
Trigemina, Inc.
Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Director/Board Member | - |
Eerdere bekende functies van Bruce C. Conway
Bedrijven | Functie | Einde |
---|---|---|
CLEARPOINT NEURO, INC. | Director/Board Member | 12-04-2013 |
Whitehall Corp.
Whitehall Corp. Aerospace & DefenseElectronic Technology Part of Hong Kong Aircraft Engineering Co., Ltd., Whitehall Corp. is a private company that makes and sells marine sensing systems. The company is based in Dallas, TX. Whitehall was acquired by Aviation Sales Co. on July 31, 1998 for $103.27 million. | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CLEARPOINT NEURO, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Whitehall Corp.
Whitehall Corp. Aerospace & DefenseElectronic Technology Part of Hong Kong Aircraft Engineering Co., Ltd., Whitehall Corp. is a private company that makes and sells marine sensing systems. The company is based in Dallas, TX. Whitehall was acquired by Aviation Sales Co. on July 31, 1998 for $103.27 million. | Electronic Technology |
Trigemina, Inc.
Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Health Technology |